Peter Goodhand


Executive Director, Global Alliance for Genomics and Health
Peter Goodhand played a key role in the creation of the Global Alliance for Genomics and Health (GA4GH) and was appointed as its founding Executive Director in 2014. He was appointed the President of OICR in March, 2017 after spending a year as the Interim President. Previously, Goodhand was the President and CEO of the Canadian Cancer Society. Before joining the charitable sector, he had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies such as American Cyanamid and Johnson & Johnson and as the founding Managing Director of the Health Technology Exchange (HTX).